Foundation for Medical Research, Maharashtra, India.
J Clin Neurophysiol. 2010 Feb;27(1):38-47. doi: 10.1097/WNP.0b013e3181cb426d.
The purpose of this study is to determine the extent of nerve involvement and to study the effect of corticosteroids combined with multidrug therapy on nerve damage in leprosy patients using sensory and motor nerve conduction studies. A cohort of 365 untreated multibacillary leprosy patients were prospectively studied using sensory and motor nerve conduction studies on upper and lower limb nerves. They were subgrouped as those to be treated with 12-week regimen of corticosteroids for reaction and/or neuritis or silent neuropathy of <6 months duration along with 12-month multidrug therapy (group A), and those with no reaction were treated with multidrug therapy only (group B). Analysis was performed using SPSS version 10.0. Significance of association was tested using chi(2) test. At registration, abnormality by nerve conduction studies was seen in 92% of patients and majority (65%) showing involvement of more than five sensory and motor nerves. Sensory nerve abnormalities were higher (52%) than motor (37%) (P < 0.001). Affection of sensory and motor nerves was higher in group A (P < 0.001). Notably, 40% nerves in group B also showed impairment at 0 month. This implies that almost all patients showed abnormal nerve conduction studies at onset regardless of reaction, proving nerve damage is more widespread than envisaged. At 18 months, overall percentile deterioration (23%) of nerves was higher than improvement (9%) (P < 0.001) indicating that corticosteroids combined with multidrug therapy failed to significantly improve the nerve status. Sensory nerve (57%) affection was significantly higher than motor (46%) (P < 0.001). Moreover, percentile deterioration of sensory nerves was higher in group A (P < 0.001) implying corticosteroids is not very efficacious in the prevention or reversal of nerve damage. Electrophysiological tests provide valuable information for detecting nerve function impairment and evaluating appropriate therapeutic regimens.
本研究旨在通过感觉和运动神经传导研究确定神经受累程度,并研究皮质类固醇联合多药治疗对麻风病患者神经损伤的影响。前瞻性研究了 365 例未经治疗的多菌型麻风病患者,对其上肢和下肢神经进行了感觉和运动神经传导研究。根据是否接受为期 12 周的皮质类固醇治疗反应和/或神经炎或 <6 个月的无症状神经病变,以及是否接受为期 12 个月的多药治疗(A 组),将患者分为亚组;无反应者仅接受多药治疗(B 组)。使用 SPSS 版本 10.0 进行分析。使用卡方检验检验相关性的显著性。在登记时,92%的患者通过神经传导研究发现异常,大多数(65%)患者有超过 5 条感觉和运动神经受累。感觉神经异常(52%)高于运动神经异常(37%)(P < 0.001)。A 组感觉和运动神经受累更高(P < 0.001)。值得注意的是,B 组也有 40%的神经在 0 个月时出现损伤。这意味着几乎所有患者在发病时都表现出异常的神经传导研究,证明神经损伤比预期的更广泛。在 18 个月时,神经的总体百分比恶化(23%)高于改善(9%)(P < 0.001),表明皮质类固醇联合多药治疗未能显著改善神经状况。感觉神经(57%)受累明显高于运动神经(46%)(P < 0.001)。此外,A 组感觉神经的百分比恶化更高(P < 0.001),这表明皮质类固醇在预防或逆转神经损伤方面效果不佳。电生理测试为检测神经功能损伤和评估适当的治疗方案提供了有价值的信息。